21385-Rectal Cancer-NA-466

Rectal Cancer

Epidemiological study to determine the prevalence of ctDNA positivity in participants with Stage II (high risk) or Stage III CRC after surgery with curative (R0) intent and subsequent adjuvant chemotherapy with monitoring of ctDNA during clinical follow-up (BNT000-001)

  • Details

ClinicalTrials.gov ID: NCT04813627
Diagnosis Type: NA
USOR Number:

  • Address

265 North Broadway
Portland, OR 97227
P: (503) 280-1223

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.